137 related articles for article (PubMed ID: 38244810)
1. Physiologically based pharmacokinetic modeling to predict maternal pharmacokinetics and fetal carbamazepine exposure during pregnancy.
Chen Y; Ke M; Fang W; Jiang Y; Lin R; Wu W; Huang P; Lin C
Eur J Pharm Sci; 2024 Mar; 194():106707. PubMed ID: 38244810
[TBL] [Abstract][Full Text] [Related]
2. Application of PBPK modeling in predicting maternal and fetal pharmacokinetics of levetiracetam during pregnancy.
Chen J; You X; Wu W; Guo G; Lin R; Ke M; Huang P; Lin C
Eur J Pharm Sci; 2023 Feb; 181():106349. PubMed ID: 36496167
[TBL] [Abstract][Full Text] [Related]
3. Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.
Liu XI; Momper JD; Rakhmanina N; van den Anker JN; Green DJ; Burckart GJ; Best BM; Mirochnick M; Capparelli EV; Dallmann A
J Clin Pharmacol; 2020 Feb; 60(2):240-255. PubMed ID: 31489678
[TBL] [Abstract][Full Text] [Related]
4. Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine.
He L; Ke M; Wu W; Chen J; Guo G; Lin R; Huang P; Lin C
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365185
[TBL] [Abstract][Full Text] [Related]
5. Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling.
Schalkwijk S; Buaben AO; Freriksen JJM; Colbers AP; Burger DM; Greupink R; Russel FGM
Clin Pharmacokinet; 2018 Jun; 57(6):705-716. PubMed ID: 28744795
[TBL] [Abstract][Full Text] [Related]
6. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome.
van Hoogdalem MW; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
Pharmacol Ther; 2022 Jun; 234():108045. PubMed ID: 34813863
[TBL] [Abstract][Full Text] [Related]
7. Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach.
Van Der Heijden JEM; Van Hove H; Van Elst NM; Van Den Broek P; Van Drongelen J; Scheepers HCJ; De Wildt SN; Greupink R
Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38763343
[TBL] [Abstract][Full Text] [Related]
8. Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.
Balhara A; Kumar AR; Unadkat JD
J Clin Pharmacol; 2022 Sep; 62 Suppl 1(Suppl 1):S94-S114. PubMed ID: 36106781
[TBL] [Abstract][Full Text] [Related]
9. Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus.
Mian P; Allegaert K; Conings S; Annaert P; Tibboel D; Pfister M; van Calsteren K; van den Anker JN; Dallmann A
Clin Pharmacokinet; 2020 Jul; 59(7):911-925. PubMed ID: 32052378
[TBL] [Abstract][Full Text] [Related]
10. Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
Peng J; Ladumor MK; Unadkat JD
Drug Metab Dispos; 2022 May; 50(5):613-623. PubMed ID: 35149540
[TBL] [Abstract][Full Text] [Related]
11. Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
De Sousa Mendes M; Hirt D; Vinot C; Valade E; Lui G; Pressiat C; Bouazza N; Foissac F; Blanche S; Lê MP; Peytavin G; Treluyer JM; Urien S; Benaboud S
Br J Clin Pharmacol; 2016 Apr; 81(4):646-57. PubMed ID: 26518984
[TBL] [Abstract][Full Text] [Related]
12. Physiologically-Based Pharmacokinetic Modeling of Tenofovir Disoproxil Fumarate in Pregnant Women.
Zhang X; Luo T; Yang H; Ma WY; He Q; Xu M; Yang Y
Curr Drug Metab; 2023; 23(14):1115-1123. PubMed ID: 36718061
[TBL] [Abstract][Full Text] [Related]
13. Prediction of maternal and fetal pharmacokinetics of indomethacin in pregnancy.
Pillai VC; Shah M; Rytting E; Nanovskaya TN; Wang X; Clark SM; Ahmed MS; Hankins GDV; Caritis SN; Venkataramanan R
Br J Clin Pharmacol; 2022 Jan; 88(1):271-281. PubMed ID: 34185331
[TBL] [Abstract][Full Text] [Related]
14. Development of a physiologically based toxicokinetic model for lead in pregnant women: The role of bone tissue in the maternal and fetal internal exposure.
Ali Daoud Y; Tebby C; Beaudouin R; Brochot C
Toxicol Appl Pharmacol; 2023 Oct; 476():116651. PubMed ID: 37549741
[TBL] [Abstract][Full Text] [Related]
15. A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.
De Sousa Mendes M; Lui G; Zheng Y; Pressiat C; Hirt D; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Urien S; Benaboud S
Clin Pharmacokinet; 2017 May; 56(5):537-550. PubMed ID: 27766562
[TBL] [Abstract][Full Text] [Related]
16. Physiologically-based pharmacokinetic models to predict drug exposure during pregnancy.
Ait-Chikh C; Page G; Thoreau V
Ann Pharm Fr; 2024 Mar; 82(2):236-242. PubMed ID: 37739215
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments.
Bukkems VE; van Hove H; Roelofsen D; Freriksen JJM; van Ewijk-Beneken Kolmer EWJ; Burger DM; van Drongelen J; Svensson EM; Greupink R; Colbers A
Clin Pharmacokinet; 2022 Aug; 61(8):1129-1141. PubMed ID: 35579825
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.
Abduljalil K; Pansari A; Ning J; Jamei M
Clin Pharmacokinet; 2022 May; 61(5):725-748. PubMed ID: 35067869
[TBL] [Abstract][Full Text] [Related]
19. Gestational changes in buprenorphine exposure: A physiologically-based pharmacokinetic analysis.
Zhang H; Kalluri HV; Bastian JR; Chen H; Alshabi A; Caritis SN; Venkataramanan R
Br J Clin Pharmacol; 2018 Sep; 84(9):2075-2087. PubMed ID: 29873094
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
